1-176557044-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020318.3(PAPPA2):āc.722A>Gā(p.Gln241Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,613,704 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020318.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAPPA2 | NM_020318.3 | c.722A>G | p.Gln241Arg | missense_variant | 2/23 | ENST00000367662.5 | NP_064714.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAPPA2 | ENST00000367662.5 | c.722A>G | p.Gln241Arg | missense_variant | 2/23 | 1 | NM_020318.3 | ENSP00000356634 | P1 | |
PAPPA2 | ENST00000367661.7 | c.722A>G | p.Gln241Arg | missense_variant | 2/5 | 1 | ENSP00000356633 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151814Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 249490Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135348
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461890Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727244
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151814Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74156
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.722A>G (p.Q241R) alteration is located in exon 2 (coding exon 1) of the PAPPA2 gene. This alteration results from a A to G substitution at nucleotide position 722, causing the glutamine (Q) at amino acid position 241 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at